DYN Dyne Therapeutics, Inc.
Healthcare$17.37+0.00%ClosedMarket Cap: $2.87B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$37.40
Target (Median)
$38.50
Target Range
$23.00 - $60.00
Upside from current price: 115.3%
Rating Distribution
3 Strong Buy11 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-13 | Bernstein | maintain | Market Perform | Market Perform |
| 2026-03-09 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-03 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-01-20 | JP Morgan | maintain | Neutral | Neutral |
| 2025-12-15 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2025-12-11 | Stifel | maintain | Buy | Buy |
| 2025-12-10 | Oppenheimer | upgrade | Outperform | Perform |
| 2025-12-09 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.94 | $51.3M | 11 |
| Sun Dec 31 | $-2.18 | $284.6M | 9 |
| Mon Dec 31 | $-0.15 | $827.7M | 3 |
| Tue Dec 31 | $2.09 | $1.39B | 3 |